Skip to content

Latest

Pringles brings back Thanksgiving-inspired favorites

Pringles brings back Thanksgiving-inspired favorites

Last Thanksgiving, Pringles showed the world they deserve a seat at the table when they launched the Pringles Thanksgiving Dinner. The limited time only offering gave snackers the chance to taste eight new innovative, Thanksgiving-inspired flavors.

Walmart gets ready for what comes next

Walmart gets ready for what comes next

Despite all the attention that Amazon justifiably receives for the transformational effect it is exerting on mass market retailing, a case can be made that the company that is in the best position to meet the omnichannel needs of consumers over the long term is Walmart.

Congress views DIR fee impact, pharmacy value on home turf

Congress views DIR fee impact, pharmacy value on home turf

Lawmakers back in their congressional districts while Congress is on recess had an opportunity through the NACDS RxIMPACT grassroots advocacy program to discuss with pharmacists the critical repercussions caused by pharmacy direct and indirect remuneration (DIR) fees.

Retail clinics are driving in-store purchases reports Civis Analytics

Retail clinics are driving in-store purchases reports Civis Analytics

Civis Analytics, a data science firm that empowers organizations to make smarter, faster decisions grounded in statistical facts, released new research that explores demographics and motivations of retail clinic patients, and how these visits impact spending behavior in the retail portion of the sto

Aquestive Therapeutics announces FDA approval for Sympazan

Aquestive Therapeutics announces FDA approval for Sympazan

WARREN, N.J. – Aquestive Therapeutics announced that the U.S. Food and Drug Administration (FDA) approved Sympazan (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.